News Agency
The Times

Pierre Fabre Laboratories to accelerate their development in onco-hematology by acquiring the license for a breakthrough T-cell immunotherapy in North America

  • Written by PR Newswire
Pierre Fabre Laboratories to accelerate their development in onco-hematology by acquiring the license for a breakthrough T-cell immunotherapy in North America

Pierre Fabre Laboratories to Acquire from Atara Biotherapeutics Commercialization Rights to EBVALLO® in the United States, Canada and All Remaining Markets

Pierre Fabre Laboratories to Take Over All Manufacturing, Clinical, and Regulatory Activities for EBVALLO® Following Transition Period

This strategic acquisition enables Pierre Fabre...

Read more: Pierre Fabre Laboratories to accelerate their development in onco-hematology by acquiring the...

How Can Businesses Reduce the Risk of Commercial Litigation?

Commercial disputes often begin with a misunderstanding, an unclear contract or a delayed response to a growing problem. Seeking early advice from Litigation Lawyers Sydney with PCL lawyers can help businesses trust and identify legal risks, clarify obligations and create a strategy... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion